Novel Functional Testing For Early Diabetic Retinopathy
Funder
National Health and Medical Research Council
Funding Amount
$447,578.00
Summary
About 7.5% of Australians have diabetes and 62% of them will have signs of damage to their eyes within 6 years of diagnosis. Diabetes is 2 to 3 times more common amongst Aboriginal Australians. A group of researchers at the Australian National University are collaborating to bring a new test for the severity of diabetic eye disease to the market within 3 years. The objective is to provide doctors with a rapid, cost-effective tool to help them recognize sight-threatening damage and to assist in t ....About 7.5% of Australians have diabetes and 62% of them will have signs of damage to their eyes within 6 years of diagnosis. Diabetes is 2 to 3 times more common amongst Aboriginal Australians. A group of researchers at the Australian National University are collaborating to bring a new test for the severity of diabetic eye disease to the market within 3 years. The objective is to provide doctors with a rapid, cost-effective tool to help them recognize sight-threatening damage and to assist in treatment.Read moreRead less
A System For Measurement Of Vision-specific Quality Of Life Using Item Banking And Computer Adaptive Testing (ViSBank)
Funder
National Health and Medical Research Council
Funding Amount
$831,155.00
Summary
When evaluating medical treatments, it is important to consider all effects from the patient’s perspective; their quality of life. This project utilises new technology to develop an adaptable, computerised, internet-based system to measure the effects of eye diseases and their treatments on patients’ quality of life. This system will provide for more accurate, precise and efficient measurement than existing methods.
Investigating Trans-synaptic Degeneration In The Human Visual Pathway
Funder
National Health and Medical Research Council
Funding Amount
$79,514.00
Summary
This research project investigates the spread of neuronal damage along the visual pathway from the retina to higher order areas including the visual cortex and inter-hemispheric tracts. This trans-synaptic degeneration will be examined in Leber's optic atrophy, optic neuritis and glaucoma.
Managing Depression Within Low Vision Rehabilitation Services: The Effectiveness Of Integrating An Evidence-based Therapy ‘Problem-Solving Therapy For Primary Care’ On Depression, Quality Of Life And Service Utilisation In Those With Low Vision
Funder
National Health and Medical Research Council
Funding Amount
$92,785.00
Summary
This research will evaluate the integration of an evidence-based treatment for depression into low vision rehabilitation services. It is anticipated that this new program will lead to sustained improvements in participants’ quality of life and mental health. This is the first time a system to manage depression has been implemented into low vision services worldwide and if successful this intervention could be suitable for application to other chronic health conditions.
Determinants Of Perfect Vision: The Raine Eye Health Study, An Ophthalmic Follow-up Study Of A Longitudinal Birth Cohort At Age 21 Years
Funder
National Health and Medical Research Council
Funding Amount
$59,295.00
Summary
Parents aim to do the best for their child�s development, however little is known about what is required for children to develop perfect vision. This study will analyse those modifiable antenatal, early life and childhood factors that influence visual acuity in later life. Using ocular data from the Raine Health Study, which prospectively follows a cohort of 1,500 young adults, we will describe normal eye function in early adulthood and investigate the genetic and environmental factors predispos ....Parents aim to do the best for their child�s development, however little is known about what is required for children to develop perfect vision. This study will analyse those modifiable antenatal, early life and childhood factors that influence visual acuity in later life. Using ocular data from the Raine Health Study, which prospectively follows a cohort of 1,500 young adults, we will describe normal eye function in early adulthood and investigate the genetic and environmental factors predisposing to visal acuity.Read moreRead less
Investigating The Mechanisms Underpinning The Dynamic Vessel Response In People With Diabetic Retinopathy
Funder
National Health and Medical Research Council
Funding Amount
$18,808.00
Summary
Endothelial dysfunction has been well-hypothesised as one of the key players in the pathogenesis of DR. However, there is strong evidence suggesting a neurovascular coupling mechanism in the retinal circulation during flicker. It is therefore unclear whether reduced flicker light induced vasodilation observed in diabetes and DR is associated with endothelial dysfunction, an impairment of neurovascular coupling or both. This project aims to address this important knowledge gap.
Functional Analysis Of Recently Identified Novel Glaucoma Genes.
Funder
National Health and Medical Research Council
Funding Amount
$519,918.00
Summary
Glaucoma is the commonest cause of irreversible blindness in the world. Recently, through genetic studies in cohorts of blinding glaucoma cases from Australia, our group has found that variants in two genes increase the risk of blinding glaucoma. This project will investigate how these genes contribute to pathological changes in the optic nerve and retina, at the back of the eye, that lead to glaucoma. This knowledge will be useful for developing new strategies to treat glaucoma.
The Role Of EphA2 Signalling And Environmental Modifiers In Cataract.
Funder
National Health and Medical Research Council
Funding Amount
$591,547.00
Summary
In cataract the clear lens in the eye becomes opaque causing blindness. Cataract is very common in the elderly, but is rarely also seen in babies and children. In babies certain gene defects, and in the elderly the genes and environmental factors contribute to cataract. The EPHA2 gene causes cataract in both young and old people. This project aims to understand how EPHA2 and other related genes cause cataract in young and old people, to prevent, delay or improve its treatment in the future.